Stifel Reiterates Buy Rating on FRMI

Stifel has reiterated its buy rating on FRMI, setting a price target of $17. This update, delivered by analyst Stephen Gengaro on June 23, 2026, underscores Stifel's continued confidence in the company's prospects.

Other Institutional Activity in FRMI

Several institutional investors have made notable adjustments to their FRMI holdings. UBS Group AG boosted its position by 6,267,254 shares, ending with 8,917,198 shares valued at approximately $52.1 million, marking a 236.5% increase. Citadel Advisors LLC increased its stake by 4,989,531 shares, resulting in 6,221,706 shares worth about $36.3 million, a 404.9% rise. Goldman Sachs Group Inc. made a significant move, adding 5,372,287 shares to reach 5,437,457 shares, valued at around $31.8 million, reflecting an 8,243.5% increase. Barclays PLC also increased its stake by 2,955,901 shares to hold 3,025,437 shares, valued at approximately $17.7 million, a 4,250.9% jump. Meanwhile, T. Rowe Price Investment Management, Inc. opened a new position with 2,473,357 shares valued at $14.4 million.

Fermi Inc. Stock Up 59.8%

Shares of FRMI traded near $8.97 on Tuesday. The stock has faced fluctuations, with a 52-week low and high not specified in the available data. The company's current market performance and valuation metrics were not detailed, but investors are closely watching its trading activity and institutional movements.

Insider Buying and Selling at Fermi Inc.

Recent insider activity at FRMI includes several purchases. On June 1, 2026, insiders such as Marius Haas and Jeffrey Scott Stein bought 175,094 and 250,000 shares, respectively, albeit at a price of $0.00, which might indicate non-cash transactions or stock awards. Chief Power Officer Lawrence Kellerman purchased 35,818 shares, and Cordel Robbin-Coker acquired 175,094 shares on the same day. In contrast, Chief Nuclear Construction Officer Uzman Mesut sold 158,541 shares on June 3, 2026, at an average price of $6.31.

Analysts Set New Price Targets

On June 23, 2026, Stifel maintained its buy rating on FRMI with a $17 price target. Earlier, on May 15, 2026, Evercore ISI Group downgraded the stock to a hold with an $11 target. Meanwhile, Macquarie has consistently maintained a buy rating, most recently with a $20 target set on April 20, 2026. The consensus among analysts suggests a positive outlook, with multiple buy ratings and varying price targets reflecting differing views on FRMI's valuation potential.

Bottom Line

Stifel's reiterated buy rating and $17 target for FRMI highlight ongoing confidence in the company's growth potential. Investors are keeping an eye on significant insider purchases and institutional interest, which may indicate broader market sentiment. As always, 13F filings and analyst reports are backward-looking, providing a snapshot of past decisions and perspectives.